Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Decision Making in Adrenoleukodystrophy

Decision Making in Adrenoleukodystrophy Editorial Opinion 9. Kleindorfer D, Khoury J, Alwell K, et al. The 11. Office of Inspector General, Department of 13. Kissela BM, Khoury JC, Alwell K, et al. Age at impact of magnetic resonance imaging (MRI) on Health and Human Services. Coding trends of stroke: temporal trends in stroke incidence in a ischemic stroke detection and incidence: minimal Medicare evaluation and management services. large, biracial population. Neurology. 2012;79(17): impact within a population-based study. BMC Neurol. https://oig.hhs.gov/oei/reports/oei-04-10-00180 1781-1787. 2015;15(1):175. .pdf. Accessed February 1, 2017. 14. Morgenstern LB, Smith MA, Sánchez BN, et al. 10. Betjemann JP, Josephson SA, Lowenstein DH, 12. Ramirez L, Kim-Tenser MA, Sanossian N, et al. Persistent ischemic stroke disparities despite Burke JF. Trends in status epilepticus-related Trends in transient ischemic attack hospitalizations declining incidence in Mexican Americans. Ann hospitalizations and mortality: redefined in US in the United States. J Am Heart Assoc. 2016;5(9): Neurol. 2013;74(6):778-785. practice over time. JAMA Neurol. 2015;72(6):650-655. e004026. When Is a Good Outcome Really a Good Outcome? Keith Van Haren, MD; Marc Engelen, MD One-third of boys with adrenoleukodystrophy (ALD) will de- which increased to 48% for those with more advanced dis- velop inflammatory brain lesions (ie, cerebral ALD [cALD]) in ease http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Neurology American Medical Association

Decision Making in Adrenoleukodystrophy

Van Haren, Keith; Engelen, Marc
JAMA Neurology , Volume 74 (6) – Jun 17, 2017
Download PDF
2 pages

Loading next page...
 
/lp/american-medical-association/decision-making-in-adrenoleukodystrophy-RNebebYOs0
Publisher
American Medical Association
Copyright
Copyright 2017 American Medical Association. All Rights Reserved.
ISSN
2168-6149
eISSN
2168-6157
DOI
10.1001/jamaneurol.2017.0095
Publisher site
See Article on Publisher Site

Abstract

Editorial Opinion 9. Kleindorfer D, Khoury J, Alwell K, et al. The 11. Office of Inspector General, Department of 13. Kissela BM, Khoury JC, Alwell K, et al. Age at impact of magnetic resonance imaging (MRI) on Health and Human Services. Coding trends of stroke: temporal trends in stroke incidence in a ischemic stroke detection and incidence: minimal Medicare evaluation and management services. large, biracial population. Neurology. 2012;79(17): impact within a population-based study. BMC Neurol. https://oig.hhs.gov/oei/reports/oei-04-10-00180 1781-1787. 2015;15(1):175. .pdf. Accessed February 1, 2017. 14. Morgenstern LB, Smith MA, Sánchez BN, et al. 10. Betjemann JP, Josephson SA, Lowenstein DH, 12. Ramirez L, Kim-Tenser MA, Sanossian N, et al. Persistent ischemic stroke disparities despite Burke JF. Trends in status epilepticus-related Trends in transient ischemic attack hospitalizations declining incidence in Mexican Americans. Ann hospitalizations and mortality: redefined in US in the United States. J Am Heart Assoc. 2016;5(9): Neurol. 2013;74(6):778-785. practice over time. JAMA Neurol. 2015;72(6):650-655. e004026. When Is a Good Outcome Really a Good Outcome? Keith Van Haren, MD; Marc Engelen, MD One-third of boys with adrenoleukodystrophy (ALD) will de- which increased to 48% for those with more advanced dis- velop inflammatory brain lesions (ie, cerebral ALD [cALD]) in ease

Journal

JAMA Neurology – American Medical Association

Published: Jun 17, 2017

References

  • Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation
    Aubourg, P; Blanche, S; Jambaqué, I
  • Bone marrow transplant in adrenoleukodystrophy
    Moser, HW; Tutschka, PJ; Brown, FR
  • Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy
    Shapiro, E; Krivit, W; Lockman, L
  • Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study
    Mahmood, A; Raymond, GV; Dubey, P; Peters, C; Moser, HW
  • Adrenoleukodystrophy: a scoring method for brain MR observations
    Loes, DJ; Hite, S; Moser, H
  • Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report
    Miller, WP; Rothman, SM; Nascene, D
  • Neurocognitive trajectory of boys who received a hematopoietic stem cell transplant at an early stage of childhood cerebral adrenoleukodystrophy
    Pierpont, EI; Eisengart, JB; Shanley, R
  • Brain endothelial dysfunction in cerebral adrenoleukodystrophy
    Musolino, PL; Gong, Y; Snyder, JM
  • N-acetyl-l-cysteine improves outcome of advanced cerebral adrenoleukodystrophy
    Tolar, J; Orchard, PJ; Bjoraker, KJ; Ziegler, RS; Shapiro, EG; Charnas, L
  • X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management
    Engelen, M; Kemp, S; de Visser, M
  • Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening
    Bezman, L; Moser, AB; Raymond, GV
  • Advances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disorders
    Shenoy, S; Boelens, JJ
  • Hematopoietic cell transplantation does not prevent myelopathy in X-linked adrenoleukodystrophy: a retrospective study
    van Geel, BM; Poll-The, BT; Verrips, A; Boelens, JJ; Kemp, S; Engelen, M
  • Psychological wellbeing in survivors of cardiac arrest, and its relationship to neurocognitive function
    Davies, SE; Rhys, M; Voss, S; Greenwood, R; Thomas, M; Benger, JR
  • Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma
    Maddrey, AM; Bergeron, JA; Lombardo, ER
  • Predictors of quality of life in patients with refractory mesial temporal lobe epilepsy
    Pauli, C; Thais, ME; Claudino, LS